603538.SS
603538.SS
CNE100002Y25
NINGBO MENOVO PHARMACEUTICAL CO
Loading chart...

Company Profile

Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company's products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin calcium, atorvastatin calcium, purin bahrain, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous system, gastrointestinal tract, and other therapeutic areas. The company was founded in 2004 and is headquartered in Ningbo, China.

Related stocks

002020.SZ
002020.SZ • China
JINGXIN
11.87 CNY
1.53B USD 1Y -41.5%
002675.SZ
002675.SZ • China
DONGCHENG BIOCHEM
13.89 CNY
1.71B USD 1Y -7%
000756.SZ
000756.SZ • China
XINHUA PHARM
14.81 CNY
1.54B USD 1Y -5.5%
300026.SZ
300026.SZ • China
CHASE SUN PHARM.
3.32 CNY
1.49B USD 1Y -10.8%
600285.SS
600285.SS • China
HENAN LINGRUI PHARMACEUTICAL
19.66 CNY
1.67B USD 1Y -11.5%
002550.SZ
002550.SZ • China
QIANHONG BIO-PHARMA
6.52 CNY
1.25B USD 1Y -28.4%
600488.SS
600488.SS • China
TIANJIN TIANYAO PHARMACEUTICAL
6.47 CNY
1.06B USD 1Y +59%
600422.SS
600422.SS • China
KPC PHARMACEUTICALS INC
8.36 CNY
946.93M USD 1Y -40.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
54.9% p.a.
Max Drawdown (5Y)
-83.2%
Sharpe Ratio (5Y)
0.12
Beta Factor
-0.15
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 High valuation risk: Avg P/E of 66.2 (Elevated multiple compression risk)
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (54.9% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -83.2% in the extended horizon.
ende